Humanizing Drug Discovery

Gene Editing Science Lecture Series

David Altshuler, the chief science director of Vertex Pharmaceuticals, discusses the promise of precision medicine and gene-editing therapy to potentially cure serious genetic illnesses.

Free and open to the public.

Please register and join us.

This event is part of the Gene Editing Science Lecture Series.